Baseline characteristics, disease activity at baseline and DAS28 improvement for responders and non-responders to anti-TNF treatment.
- Erik J. M. Toonen (176167)
- Christian Gilissen (176174)
- Barbara Franke (114061)
- Wietske Kievit (176181)
- Agnes M. Eijsbouts (176185)
- Alfons A. den Broeder (176189)
- Simon V. van Reijmersdal (176193)
- Joris A. Veltman (176198)
- Hans Scheffer (139830)
- Timothy R. D. J. Radstake (168224)
- Piet L. C. M. van Riel (176205)
- Pilar Barrera (176212)
- Marieke J. H. Coenen (176218)
Publication date
March 2012
DOIAbstract
<p>Results are number (percentage) or mean (SD). Percentages are expressed in relation to the total number of patients for each response group (except for the total number of patients). P-value indicates a significant difference between the two response groups NS: not significant.</p
Add to ORKG